Chimeric Therapeutics

Carlton South, Australia

Chimeric Therapeutics is a company developing ground-breaking CAR T cell therapies for solid tumors.

$2.9M raised

Dec 2025

Post-IPO Equity

Biotechnology Life Science Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Chimeric Therapeutics

How much funding has Chimeric Therapeutics raised?

Chimeric Therapeutics has raised $2.9M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.

Where is Chimeric Therapeutics headquartered?

Chimeric Therapeutics is headquartered in Carlton South, Australia.

What does Chimeric Therapeutics do?

Chimeric Therapeutics is a company developing ground-breaking CAR T cell therapies for solid tumors.

What stage is Chimeric Therapeutics at?

Chimeric Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 23, 2025.

MLA

"Chimeric Therapeutics — Funding & Investors." VCBacked, December 23, 2025, https://www.vcbacked.co/company/chimeric-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2025). Chimeric Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/chimeric-therapeutics

Wikipedia (cite web)

{{cite web |title=Chimeric Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/chimeric-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 23, 2025.